The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adoptive Cellular Immunotherapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 TIL
1.2.3 LAK
1.2.4 CAR-T
1.2.5 TCR-T
1.2.6 CIK
1.2.7 NK
1.2.8 DC
1.2.9 Other
1.3 Market by Application
1.3.1 Global Adoptive Cellular Immunotherapy Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Cancer Hospital
1.3.4 Centers for Disease Control and Prevention
1.3.5 Rehabilitation Center
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Adoptive Cellular Immunotherapy Market Perspective (2017-2028)
2.2 Adoptive Cellular Immunotherapy Growth Trends by Region
2.2.1 Adoptive Cellular Immunotherapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Adoptive Cellular Immunotherapy Historic Market Size by Region (2017-2022)
2.2.3 Adoptive Cellular Immunotherapy Forecasted Market Size by Region (2023-2028)
2.3 Adoptive Cellular Immunotherapy Market Dynamics
2.3.1 Adoptive Cellular Immunotherapy Industry Trends
2.3.2 Adoptive Cellular Immunotherapy Market Drivers
2.3.3 Adoptive Cellular Immunotherapy Market Challenges
2.3.4 Adoptive Cellular Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adoptive Cellular Immunotherapy Players by Revenue
3.1.1 Global Top Adoptive Cellular Immunotherapy Players by Revenue (2017-2022)
3.1.2 Global Adoptive Cellular Immunotherapy Revenue Market Share by Players (2017-2022)
3.2 Global Adoptive Cellular Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Adoptive Cellular Immunotherapy Revenue
3.4 Global Adoptive Cellular Immunotherapy Market Concentration Ratio
3.4.1 Global Adoptive Cellular Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adoptive Cellular Immunotherapy Revenue in 2021
3.5 Adoptive Cellular Immunotherapy Key Players Head office and Area Served
3.6 Key Players Adoptive Cellular Immunotherapy Product Solution and Service
3.7 Date of Enter into Adoptive Cellular Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adoptive Cellular Immunotherapy Breakdown Data by Type
4.1 Global Adoptive Cellular Immunotherapy Historic Market Size by Type (2017-2022)
4.2 Global Adoptive Cellular Immunotherapy Forecasted Market Size by Type (2023-2028)
5 Adoptive Cellular Immunotherapy Breakdown Data by Application
5.1 Global Adoptive Cellular Immunotherapy Historic Market Size by Application (2017-2022)
5.2 Global Adoptive Cellular Immunotherapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Adoptive Cellular Immunotherapy Market Size (2017-2028)
6.2 North America Adoptive Cellular Immunotherapy Market Size by Country (2017-2022)
6.3 North America Adoptive Cellular Immunotherapy Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Adoptive Cellular Immunotherapy Market Size (2017-2028)
7.2 Europe Adoptive Cellular Immunotherapy Market Size by Country (2017-2022)
7.3 Europe Adoptive Cellular Immunotherapy Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adoptive Cellular Immunotherapy Market Size (2017-2028)
8.2 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Country (2017-2022)
8.3 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Adoptive Cellular Immunotherapy Market Size (2017-2028)
9.2 Latin America Adoptive Cellular Immunotherapy Market Size by Country (2017-2022)
9.3 Latin America Adoptive Cellular Immunotherapy Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adoptive Cellular Immunotherapy Market Size (2017-2028)
10.2 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Country (2017-2022)
10.3 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Amgen Inc
11.1.1 Amgen Inc Company Detail
11.1.2 Amgen Inc Business Overview
11.1.3 Amgen Inc Adoptive Cellular Immunotherapy Introduction
11.1.4 Amgen Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.1.5 Amgen Inc Recent Development
11.2 Autolus Therapeutics Plc
11.2.1 Autolus Therapeutics Plc Company Detail
11.2.2 Autolus Therapeutics Plc Business Overview
11.2.3 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Introduction
11.2.4 Autolus Therapeutics Plc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.2.5 Autolus Therapeutics Plc Recent Development
11.3 Beijing Immunochina Medical Science & Technology Co Ltd
11.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Detail
11.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Business Overview
11.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Introduction
11.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Recent Development
11.4 Bellicum Pharmaceuticals Inc
11.4.1 Bellicum Pharmaceuticals Inc Company Detail
11.4.2 Bellicum Pharmaceuticals Inc Business Overview
11.4.3 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Introduction
11.4.4 Bellicum Pharmaceuticals Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.4.5 Bellicum Pharmaceuticals Inc Recent Development
11.5 Bristol-Myers Squibb Co
11.5.1 Bristol-Myers Squibb Co Company Detail
11.5.2 Bristol-Myers Squibb Co Business Overview
11.5.3 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Introduction
11.5.4 Bristol-Myers Squibb Co Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.5.5 Bristol-Myers Squibb Co Recent Development
11.6 bluebird bio Inc
11.6.1 bluebird bio Inc Company Detail
11.6.2 bluebird bio Inc Business Overview
11.6.3 bluebird bio Inc Adoptive Cellular Immunotherapy Introduction
11.6.4 bluebird bio Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.6.5 bluebird bio Inc Recent Development
11.7 CARsgen Therapeutics Ltd
11.7.1 CARsgen Therapeutics Ltd Company Detail
11.7.2 CARsgen Therapeutics Ltd Business Overview
11.7.3 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Introduction
11.7.4 CARsgen Therapeutics Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.7.5 CARsgen Therapeutics Ltd Recent Development
11.8 Celgene Corp
11.8.1 Celgene Corp Company Detail
11.8.2 Celgene Corp Business Overview
11.8.3 Celgene Corp Adoptive Cellular Immunotherapy Introduction
11.8.4 Celgene Corp Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.8.5 Celgene Corp Recent Development
11.9 Cell Medica Ltd
11.9.1 Cell Medica Ltd Company Detail
11.9.2 Cell Medica Ltd Business Overview
11.9.3 Cell Medica Ltd Adoptive Cellular Immunotherapy Introduction
11.9.4 Cell Medica Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.9.5 Cell Medica Ltd Recent Development
11.10 Cellular Biomedicine Group Inc
11.10.1 Cellular Biomedicine Group Inc Company Detail
11.10.2 Cellular Biomedicine Group Inc Business Overview
11.10.3 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Introduction
11.10.4 Cellular Biomedicine Group Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.10.5 Cellular Biomedicine Group Inc Recent Development
11.11 Celularity Inc
11.11.1 Celularity Inc Company Detail
11.11.2 Celularity Inc Business Overview
11.11.3 Celularity Inc Adoptive Cellular Immunotherapy Introduction
11.11.4 Celularity Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.11.5 Celularity Inc Recent Development
11.12 Celyad SA
11.12.1 Celyad SA Company Detail
11.12.2 Celyad SA Business Overview
11.12.3 Celyad SA Adoptive Cellular Immunotherapy Introduction
11.12.4 Celyad SA Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.12.5 Celyad SA Recent Development
11.13 Daiichi Sankyo Co Ltd
11.13.1 Daiichi Sankyo Co Ltd Company Detail
11.13.2 Daiichi Sankyo Co Ltd Business Overview
11.13.3 Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Introduction
11.13.4 Daiichi Sankyo Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.13.5 Daiichi Sankyo Co Ltd Recent Development
11.14 Fosun Pharmaceutical AG
11.14.1 Fosun Pharmaceutical AG Company Detail
11.14.2 Fosun Pharmaceutical AG Business Overview
11.14.3 Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Introduction
11.14.4 Fosun Pharmaceutical AG Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.14.5 Fosun Pharmaceutical AG Recent Development
11.15 Gilead Sciences Inc
11.15.1 Gilead Sciences Inc Company Detail
11.15.2 Gilead Sciences Inc Business Overview
11.15.3 Gilead Sciences Inc Adoptive Cellular Immunotherapy Introduction
11.15.4 Gilead Sciences Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.15.5 Gilead Sciences Inc Recent Development
11.16 Guangzhou Anjie Biomedical Technology Co Ltd
11.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Detail
11.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
11.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Introduction
11.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Recent Development
11.17 Hangzhou Converd Co Ltd
11.17.1 Hangzhou Converd Co Ltd Company Detail
11.17.2 Hangzhou Converd Co Ltd Business Overview
11.17.3 Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Introduction
11.17.4 Hangzhou Converd Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.17.5 Hangzhou Converd Co Ltd Recent Development
11.18 Hebei Senlang Biotechnology Inc Ltd
11.18.1 Hebei Senlang Biotechnology Inc Ltd Company Detail
11.18.2 Hebei Senlang Biotechnology Inc Ltd Business Overview
11.18.3 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Introduction
11.18.4 Hebei Senlang Biotechnology Inc Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.18.5 Hebei Senlang Biotechnology Inc Ltd Recent Development
11.19 HRAIN Biotechnology Co Ltd
11.19.1 HRAIN Biotechnology Co Ltd Company Detail
11.19.2 HRAIN Biotechnology Co Ltd Business Overview
11.19.3 HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Introduction
11.19.4 HRAIN Biotechnology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.19.5 HRAIN Biotechnology Co Ltd Recent Development
11.20 Juno Therapeutics Inc
11.20.1 Juno Therapeutics Inc Company Detail
11.20.2 Juno Therapeutics Inc Business Overview
11.20.3 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Introduction
11.20.4 Juno Therapeutics Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.20.5 Juno Therapeutics Inc Recent Development
11.21 Kite Pharma Inc
11.21.1 Kite Pharma Inc Company Detail
11.21.2 Kite Pharma Inc Business Overview
11.21.3 Kite Pharma Inc Adoptive Cellular Immunotherapy Introduction
11.21.4 Kite Pharma Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.21.5 Kite Pharma Inc Recent Development
11.22 Nanjing Legend Biotech Co Ltd
11.22.1 Nanjing Legend Biotech Co Ltd Company Detail
11.22.2 Nanjing Legend Biotech Co Ltd Business Overview
11.22.3 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Introduction
11.22.4 Nanjing Legend Biotech Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.22.5 Nanjing Legend Biotech Co Ltd Recent Development
11.23 NantKwest Inc
11.23.1 NantKwest Inc Company Detail
11.23.2 NantKwest Inc Business Overview
11.23.3 NantKwest Inc Adoptive Cellular Immunotherapy Introduction
11.23.4 NantKwest Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.23.5 NantKwest Inc Recent Development
11.24 Nkarta Inc
11.24.1 Nkarta Inc Company Detail
11.24.2 Nkarta Inc Business Overview
11.24.3 Nkarta Inc Adoptive Cellular Immunotherapy Introduction
11.24.4 Nkarta Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.24.5 Nkarta Inc Recent Development
11.25 Novartis AG
11.25.1 Novartis AG Company Detail
11.25.2 Novartis AG Business Overview
11.25.3 Novartis AG Adoptive Cellular Immunotherapy Introduction
11.25.4 Novartis AG Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.25.5 Novartis AG Recent Development
11.26 Ono Pharmaceutical Co Ltd
11.26.1 Ono Pharmaceutical Co Ltd Company Detail
11.26.2 Ono Pharmaceutical Co Ltd Business Overview
11.26.3 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Introduction
11.26.4 Ono Pharmaceutical Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.26.5 Ono Pharmaceutical Co Ltd Recent Development
11.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
11.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Detail
11.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
11.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Introduction
11.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development
11.28 Sorrento Therapeutics Inc
11.28.1 Sorrento Therapeutics Inc Company Detail
11.28.2 Sorrento Therapeutics Inc Business Overview
11.28.3 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Introduction
11.28.4 Sorrento Therapeutics Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.28.5 Sorrento Therapeutics Inc Recent Development
11.29 Takara Bio Inc
11.29.1 Takara Bio Inc Company Detail
11.29.2 Takara Bio Inc Business Overview
11.29.3 Takara Bio Inc Adoptive Cellular Immunotherapy Introduction
11.29.4 Takara Bio Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.29.5 Takara Bio Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Adoptive Cellular Immunotherapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of TIL
Table 3. Key Players of LAK
Table 4. Key Players of CAR-T
Table 5. Key Players of TCR-T
Table 6. Key Players of CIK
Table 7. Key Players of NK
Table 8. Key Players of DC
Table 9. Key Players of Other
Table 10. Global Adoptive Cellular Immunotherapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Adoptive Cellular Immunotherapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 12. Global Adoptive Cellular Immunotherapy Market Size by Region (2017-2022) & (US$ Million)
Table 13. Global Adoptive Cellular Immunotherapy Market Share by Region (2017-2022)
Table 14. Global Adoptive Cellular Immunotherapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 15. Global Adoptive Cellular Immunotherapy Market Share by Region (2023-2028)
Table 16. Adoptive Cellular Immunotherapy Market Trends
Table 17. Adoptive Cellular Immunotherapy Market Drivers
Table 18. Adoptive Cellular Immunotherapy Market Challenges
Table 19. Adoptive Cellular Immunotherapy Market Restraints
Table 20. Global Adoptive Cellular Immunotherapy Revenue by Players (2017-2022) & (US$ Million)
Table 21. Global Adoptive Cellular Immunotherapy Market Share by Players (2017-2022)
Table 22. Global Top Adoptive Cellular Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cellular Immunotherapy as of 2021)
Table 23. Ranking of Global Top Adoptive Cellular Immunotherapy Companies by Revenue (US$ Million) in 2021
Table 24. Global 5 Largest Players Market Share by Adoptive Cellular Immunotherapy Revenue (CR5 and HHI) & (2017-2022)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Adoptive Cellular Immunotherapy Product Solution and Service
Table 27. Date of Enter into Adoptive Cellular Immunotherapy Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Adoptive Cellular Immunotherapy Market Size by Type (2017-2022) & (US$ Million)
Table 30. Global Adoptive Cellular Immunotherapy Revenue Market Share by Type (2017-2022)
Table 31. Global Adoptive Cellular Immunotherapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 32. Global Adoptive Cellular Immunotherapy Revenue Market Share by Type (2023-2028)
Table 33. Global Adoptive Cellular Immunotherapy Market Size by Application (2017-2022) & (US$ Million)
Table 34. Global Adoptive Cellular Immunotherapy Revenue Market Share by Application (2017-2022)
Table 35. Global Adoptive Cellular Immunotherapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 36. Global Adoptive Cellular Immunotherapy Revenue Market Share by Application (2023-2028)
Table 37. North America Adoptive Cellular Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Adoptive Cellular Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Adoptive Cellular Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
Table 40. Europe Adoptive Cellular Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
Table 41. Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Region (2017-2022) & (US$ Million)
Table 42. Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Region (2023-2028) & (US$ Million)
Table 43. Latin America Adoptive Cellular Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
Table 44. Latin America Adoptive Cellular Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
Table 45. Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
Table 46. Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
Table 47. Amgen Inc Company Detail
Table 48. Amgen Inc Business Overview
Table 49. Amgen Inc Adoptive Cellular Immunotherapy Product
Table 50. Amgen Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 51. Amgen Inc Recent Development
Table 52. Autolus Therapeutics Plc Company Detail
Table 53. Autolus Therapeutics Plc Business Overview
Table 54. Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Product
Table 55. Autolus Therapeutics Plc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 56. Autolus Therapeutics Plc Recent Development
Table 57. Beijing Immunochina Medical Science & Technology Co Ltd Company Detail
Table 58. Beijing Immunochina Medical Science & Technology Co Ltd Business Overview
Table 59. Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Product
Table 60. Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 61. Beijing Immunochina Medical Science & Technology Co Ltd Recent Development
Table 62. Bellicum Pharmaceuticals Inc Company Detail
Table 63. Bellicum Pharmaceuticals Inc Business Overview
Table 64. Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Product
Table 65. Bellicum Pharmaceuticals Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 66. Bellicum Pharmaceuticals Inc Recent Development
Table 67. Bristol-Myers Squibb Co Company Detail
Table 68. Bristol-Myers Squibb Co Business Overview
Table 69. Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Product
Table 70. Bristol-Myers Squibb Co Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 71. Bristol-Myers Squibb Co Recent Development
Table 72. bluebird bio Inc Company Detail
Table 73. bluebird bio Inc Business Overview
Table 74. bluebird bio Inc Adoptive Cellular Immunotherapy Product
Table 75. bluebird bio Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 76. bluebird bio Inc Recent Development
Table 77. CARsgen Therapeutics Ltd Company Detail
Table 78. CARsgen Therapeutics Ltd Business Overview
Table 79. CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Product
Table 80. CARsgen Therapeutics Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 81. CARsgen Therapeutics Ltd Recent Development
Table 82. Celgene Corp Company Detail
Table 83. Celgene Corp Business Overview
Table 84. Celgene Corp Adoptive Cellular Immunotherapy Product
Table 85. Celgene Corp Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 86. Celgene Corp Recent Development
Table 87. Cell Medica Ltd Company Detail
Table 88. Cell Medica Ltd Business Overview
Table 89. Cell Medica Ltd Adoptive Cellular Immunotherapy Product
Table 90. Cell Medica Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 91. Cell Medica Ltd Recent Development
Table 92. Cellular Biomedicine Group Inc Company Detail
Table 93. Cellular Biomedicine Group Inc Business Overview
Table 94. Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Product
Table 95. Cellular Biomedicine Group Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 96. Cellular Biomedicine Group Inc Recent Development
Table 97. Celularity Inc Company Detail
Table 98. Celularity Inc Business Overview
Table 99. Celularity Inc Adoptive Cellular ImmunotherapyProduct
Table 100. Celularity Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 101. Celularity Inc Recent Development
Table 102. Celyad SA Company Detail
Table 103. Celyad SA Business Overview
Table 104. Celyad SA Adoptive Cellular ImmunotherapyProduct
Table 105. Celyad SA Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 106. Celyad SA Recent Development
Table 107. Daiichi Sankyo Co Ltd Company Detail
Table 108. Daiichi Sankyo Co Ltd Business Overview
Table 109. Daiichi Sankyo Co Ltd Adoptive Cellular ImmunotherapyProduct
Table 110. Daiichi Sankyo Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 111. Daiichi Sankyo Co Ltd Recent Development
Table 112. Fosun Pharmaceutical AG Company Detail
Table 113. Fosun Pharmaceutical AG Business Overview
Table 114. Fosun Pharmaceutical AG Adoptive Cellular ImmunotherapyProduct
Table 115. Fosun Pharmaceutical AG Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 116. Fosun Pharmaceutical AG Recent Development
Table 117. Gilead Sciences Inc Company Detail
Table 118. Gilead Sciences Inc Business Overview
Table 119. Gilead Sciences Inc Adoptive Cellular ImmunotherapyProduct
Table 120. Gilead Sciences Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 121. Gilead Sciences Inc Recent Development
Table 122. Guangzhou Anjie Biomedical Technology Co Ltd Company Detail
Table 123. Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
Table 124. Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular ImmunotherapyProduct
Table 125. Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 126. Guangzhou Anjie Biomedical Technology Co Ltd Recent Development
Table 127. Hangzhou Converd Co Ltd Company Detail
Table 128. Hangzhou Converd Co Ltd Business Overview
Table 129. Hangzhou Converd Co Ltd Adoptive Cellular ImmunotherapyProduct
Table 130. Hangzhou Converd Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 131. Hangzhou Converd Co Ltd Recent Development
Table 132. Hebei Senlang Biotechnology Inc Ltd Company Detail
Table 133. Hebei Senlang Biotechnology Inc Ltd Business Overview
Table 134. Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular ImmunotherapyProduct
Table 135. Hebei Senlang Biotechnology Inc Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 136. Hebei Senlang Biotechnology Inc Ltd Recent Development
Table 137. HRAIN Biotechnology Co Ltd Company Detail
Table 138. HRAIN Biotechnology Co Ltd Business Overview
Table 139. HRAIN Biotechnology Co Ltd Adoptive Cellular ImmunotherapyProduct
Table 140. HRAIN Biotechnology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 141. HRAIN Biotechnology Co Ltd Recent Development
Table 142. Juno Therapeutics Inc Company Detail
Table 143. Juno Therapeutics Inc Business Overview
Table 144. Juno Therapeutics Inc Adoptive Cellular ImmunotherapyProduct
Table 145. Juno Therapeutics Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 146. Juno Therapeutics Inc Recent Development
Table 147. Kite Pharma Inc Company Detail
Table 148. Kite Pharma Inc Business Overview
Table 149. Kite Pharma Inc Adoptive Cellular ImmunotherapyProduct
Table 150. Kite Pharma Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 151. Kite Pharma Inc Recent Development
Table 152. Nanjing Legend Biotech Co Ltd Company Detail
Table 153. Nanjing Legend Biotech Co Ltd Business Overview
Table 154. Nanjing Legend Biotech Co Ltd Adoptive Cellular ImmunotherapyProduct
Table 155. Nanjing Legend Biotech Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 156. Nanjing Legend Biotech Co Ltd Recent Development
Table 157. NantKwest Inc Company Detail
Table 158. NantKwest Inc Business Overview
Table 159. NantKwest Inc Adoptive Cellular ImmunotherapyProduct
Table 160. NantKwest Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 161. NantKwest Inc Recent Development
Table 162. Nkarta Inc Company Detail
Table 163. Nkarta Inc Business Overview
Table 164. Nkarta Inc Adoptive Cellular ImmunotherapyProduct
Table 165. Nkarta Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 166. Nkarta Inc Recent Development
Table 167. Novartis AG Company Detail
Table 168. Novartis AG Business Overview
Table 169. Novartis AG Adoptive Cellular ImmunotherapyProduct
Table 170. Novartis AG Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 171. Novartis AG Recent Development
Table 172. Ono Pharmaceutical Co Ltd Company Detail
Table 173. Ono Pharmaceutical Co Ltd Business Overview
Table 174. Ono Pharmaceutical Co Ltd Adoptive Cellular ImmunotherapyProduct
Table 175. Ono Pharmaceutical Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 176. Ono Pharmaceutical Co Ltd Recent Development
Table 177. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Detail
Table 178. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
Table 179. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular ImmunotherapyProduct
Table 180. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 181. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development
Table 182. Sorrento Therapeutics Inc Company Detail
Table 183. Sorrento Therapeutics Inc Business Overview
Table 184. Sorrento Therapeutics Inc Adoptive Cellular ImmunotherapyProduct
Table 185. Sorrento Therapeutics Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 186. Sorrento Therapeutics Inc Recent Development
Table 187. Takara Bio Inc Company Detail
Table 188. Takara Bio Inc Business Overview
Table 189. Takara Bio Inc Adoptive Cellular ImmunotherapyProduct
Table 190. Takara Bio Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 191. Takara Bio Inc Recent Development
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adoptive Cellular Immunotherapy Market Share by Type: 2021 VS 2028
Figure 2. TIL Features
Figure 3. LAK Features
Figure 4. CAR-T Features
Figure 5. TCR-T Features
Figure 6. CIK Features
Figure 7. NK Features
Figure 8. DC Features
Figure 9. Other Features
Figure 10. Global Adoptive Cellular Immunotherapy Market Share by Application in 2021 & 2028
Figure 11. Hospital Case Studies
Figure 12. Cancer Hospital Case Studies
Figure 13. Centers for Disease Control and Prevention Case Studies
Figure 14. Rehabilitation Center Case Studies
Figure 15. Other Case Studies
Figure 16. Adoptive Cellular Immunotherapy Report Years Considered
Figure 17. Global Adoptive Cellular Immunotherapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 18. Global Adoptive Cellular Immunotherapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 19. Global Adoptive Cellular Immunotherapy Market Share by Region: 2021 VS 2028
Figure 20. Global Adoptive Cellular Immunotherapy Market Share by Players in 2021
Figure 21. Global Top Adoptive Cellular Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cellular Immunotherapy as of 2021)
Figure 22. The Top 10 and 5 Players Market Share by Adoptive Cellular Immunotherapy Revenue in 2021
Figure 23. North America Adoptive Cellular Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. North America Adoptive Cellular Immunotherapy Market Share by Country (2017-2028)
Figure 25. United States Adoptive Cellular Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Canada Adoptive Cellular Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Europe Adoptive Cellular Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Europe Adoptive Cellular Immunotherapy Market Share by Country (2017-2028)
Figure 29. Germany Adoptive Cellular Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. France Adoptive Cellular Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. U.K. Adoptive Cellular Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Italy Adoptive Cellular Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Russia Adoptive Cellular Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Nordic Countries Adoptive Cellular Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Adoptive Cellular Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Adoptive Cellular Immunotherapy Market Share by Region (2017-2028)
Figure 37. China Adoptive Cellular Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Adoptive Cellular Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Adoptive Cellular Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Adoptive Cellular Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Adoptive Cellular Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Adoptive Cellular Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Latin America Adoptive Cellular Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Latin America Adoptive Cellular Immunotherapy Market Share by Country (2017-2028)
Figure 45. Mexico Adoptive Cellular Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Adoptive Cellular Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Adoptive Cellular Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Adoptive Cellular Immunotherapy Market Share by Country (2017-2028)
Figure 49. Turkey Adoptive Cellular Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Saudi Arabia Adoptive Cellular Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Amgen Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 52. Autolus Therapeutics Plc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 53. Beijing Immunochina Medical Science & Technology Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 54. Bellicum Pharmaceuticals Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 55. Bristol-Myers Squibb Co Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 56. bluebird bio Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 57. CARsgen Therapeutics Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 58. Celgene Corp Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 59. Cell Medica Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 60. Cellular Biomedicine Group Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 61. Celularity Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 62. Celyad SA Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 63. Daiichi Sankyo Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 64. Fosun Pharmaceutical AG Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 65. Gilead Sciences Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 66. Guangzhou Anjie Biomedical Technology Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 67. Hangzhou Converd Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 68. Hebei Senlang Biotechnology Inc Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 69. HRAIN Biotechnology Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 70. Juno Therapeutics Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 71. Kite Pharma Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 72. Nanjing Legend Biotech Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 73. NantKwest Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 74. Nkarta Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 75. Novartis AG Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 76. Ono Pharmaceutical Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 77. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 78. Sorrento Therapeutics Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 79. Takara Bio Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed